SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Dov Pharmaceutical, Inc - DOVP
An SI Board Since April 2002
Posts SubjectMarks Bans Symbol
172 28 0 DOVP
Emcee:  michael_f_murphy Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
97DOV Pharmaceutical, Inc. and Merck & Co., Inc. Receive Hart-Scott-Rodino Clenigel bates-9/14/2004
96saw the news as soon as it came out. quotes showed some sitting there at REDI. scaram(o)uche-8/5/2004
95Hey, I blew it out at $13 when it was overvalued. Trading at $17 a/h. :-( I tkeokalani'nui-8/5/2004
94Aaaargh ! Another corn pops while I'm on vacation. Don't have as many nigel bates-8/5/2004
93DOV Pharmaceutical and Merck Announce Agreement to Develop and Commercialize Novkeokalani'nui-8/5/2004
92Nice, concise review. Your posts help keep us up to date on stuff where it woulscaram(o)uche-8/1/2004
91OPPY: DOVP Science Day: 7/27 Yesterday afternoon (Tuesday 7/27/04), DOVP held mopgcw-7/29/2004
90OPPY: DOVP :Indiplon Filing Clarity Positive for DOVP 2004-07-15 14:32 (New Yormopgcw-7/16/2004
89FDA Lifts Clinical Hold on DOV Pharmaceutical's Ocinaplon Subject to Protoconigel bates-6/28/2004
88DOV Pharmaceutical, Inc. Announces First Quarter 2004 Results Monday May 10, 7:3mopgcw-5/10/2004
87DOV Pharmaceutical Reports Results of End of Phase 2 Meeting with FDA and Agreemnigel bates-4/1/2004
86DOV Pharmaceutical Raises $10 million in Private Equity Transaction HACKENSACK,nigel bates-3/30/2004
85DOV Pharmaceutical, Inc., Reorganizes License Arrangements with Wyeth and Neurocnigel bates-2/27/2004
84DOV Pharmaceutical, Inc. Announces Third Quarter 2003 Results Friday November 1mopgcw-11/17/2003
83DOV Pharmaceutical, Inc. Purchases Rights to Controlled Release Formulations Of nigel bates-10/22/2003
82Hmmmm. I've changed my mind and reduced my dovp exposure. Thanks for the pkeokalani'nui-10/6/2003
81Asking For More Data, FDA Places Hold On DOV's Ocinaplon Phase III By Kim CIcebrg-10/4/2003
80PR indicate that DOV failed (incomplete) to document all necessary safety data. Miljenko Zuanic-10/4/2003
79Well I may be reading to much into this wording, but their exact words were: &lBiomaven-10/3/2003
78<<The FDA has requested that DOV PRODUCE additional safety information satMiljenko Zuanic-10/3/2003
77This is all pretty puzzling. <i>The company intends to diligently assemblBiomaven-10/3/2003
76If I had pushed this harder I might have truly appeared smart. Message 18961323keokalani'nui-10/3/2003
75nice dig of Wilder's nice dig. :-) :-( Pure luck, I bailed a couple of wescaram(o)uche-10/3/2003
74Wilder -- appears you were proven right about your concern. was there anything tom r. phillips-10/3/2003
73This would be a good time for NBIX to buy them. :-) :-(nigel bates-10/3/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News